Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04926 | 33446705 | Sci Rep | Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease. | 2021 | Details |
| A04928 | 33446095 | BMC Geriatr | Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study. | 2021 | Details |
| A04929 | 33445827 | Epidemiol Health | Renal hyperfiltration, fatty liver index, and the hazards of all-cause and cardiovascular mortality in Finnish men. | 2020 | Details |
| A04930 | 33445755 | Antioxidants (Basel) | Targeting Autophagy to Counteract Obesity-Associated Oxidative Stress. | 2021 | Details |
| A04931 | 33445719 | Int J Environ Res Public Health | Mortality Risk and Decompensation in Hospitalized Patients with Non-Alcoholic Liver Cirrhosis: Implications for Disease Management. | 2021 | Details |
| A04932 | 33445096 | J Affect Disord | Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects. | 2020 | Details |
| A04933 | 33444819 | Cell Mol Gastroenterol Hepatol | Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver. | 2021 | Details |
| A04934 | 33444725 | J Ethnopharmacol | Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota. | 2021 | Details |
| A04935 | 33444683 | Gene | Exome-wide scan identifies significant association of rs4788084 in IL27 promoter with increase in hepatic fat content among Indians. | 2021 | Details |
| A04936 | 33444607 | Metabolism | Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? | 2021 | Details |
| A04937 | 33444606 | Metabolism | Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters. | 2021 | Details |
| A04938 | 33444517 | Immunol Med | Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease. | 2021 | Details |
| A04939 | 33443240 | Minerva Gastroenterol Dietol | Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration. | 2020 | Details |
| A04940 | 33442452 | World J Hepatol | Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver. | 2020 | Details |
| A04941 | 33442450 | World J Hepatol | Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population. | 2020 | Details |
| A04942 | 33442446 | World J Hepatol | Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. | 2020 | Details |
| A04945 | 33441894 | Sci Rep | Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring. | 2021 | Details |
| A04947 | 33440736 | Nutrients | Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Lepr fa/fa Rats. | 2021 | Details |
| A04948 | 33440159 | Cell Rep | Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH. | 2021 | Details |
| A04949 | 33439893 | PLoS One | Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West. | 2021 | Details |
| A04950 | 33439540 | J Gastroenterol Hepatol | The impact of sodium glucose co-transporter 2 inhibitors on non-alcoholic fatty liver disease. | 2020 | Details |
| A04951 | 33439102 | Am J Physiol Gastrointest Liver Physiol | Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling. | 2021 | Details |
| A04952 | 33439074 | Aging Male | Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study. | 2021 | Details |
| A04953 | 33438457 | AJR Am J Roentgenol | Liver Fat Quantification by Ultrasound in Children: A Prospective Study. | 2021 | Details |
| A04955 | 33437906 | Hepatol Commun | Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma. | 2020 | Details |
| A04956 | 33437903 | Hepatol Commun | The Natural History of NAFLD, a Community-Based Study at a Large Health Care Delivery System in the United States. | 2020 | Details |
| A04957 | 33437902 | Hepatol Commun | Adherence to Ideal Cardiovascular Health Metrics Is Associated With Reduced Odds of Hepatic Steatosis. | 2020 | Details |
| A04958 | 33437901 | Hepatol Commun | Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04959 | 33437892 | Transl Gastroenterol Hepatol | Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease. | 2021 | Details |
| A04961 | 33437782 | Ann Transl Med | Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes. | 2020 | Details |
| A04962 | 33437731 | Med J Islam Repub Iran | Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients. | 2020 | Details |
| A04963 | 33436955 | Sci Rep | LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH. | 2021 | Details |
| A04964 | 33436935 | Sci Rep | Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B. | 2021 | Details |
| A04965 | 33436531 | Aging (Albany NY) | The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. | 2021 | Details |
| A04966 | 33436321 | Dig Liver Dis | Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1). | 2021 | Details |
| A04967 | 33435558 | Molecules | Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice. | 2021 | Details |
| A04968 | 33435509 | Biomedicines | The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. | 2021 | Details |
| A04969 | 33435415 | Diagnostics (Basel) | Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. | 2021 | Details |
| A04970 | 33434655 | Clin Gastroenterol Hepatol | Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04971 | 33434322 | Hepatology | Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet. | 2021 | Details |
| A04972 | 33434318 | Diabet Med | Association of liver enzymes with incident diabetes in US Hispanic/Latino adults. | 2021 | Details |
| A04973 | 33431890 | NPJ Vaccines | Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A04974 | 33431783 | Kobe J Med Sci | Non-Alcoholic Fatty Liver Disease Is Strongly Associated with Smoking Status and Is Improved by Smoking Cessation in Japanese Males: A Retrospective Study. | 2020 | Details |
| A04975 | 33431715 | Gut Liver | Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
| A04976 | 33430929 | Chin Med | Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. | 2021 | Details |
| A04977 | 33429859 | Nutrients | Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity. | 2021 | Details |
| A04978 | 33429022 | Free Radic Biol Med | Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress. | 2021 | Details |
| A04979 | 33428987 | Food Chem Toxicol | Ferulic acid ameliorates intrahepatic triglyceride accumulation in vitro but not in high fat diet-fed C57BL/6 mice. | 2021 | Details |
| A04980 | 33428035 | Dig Dis Sci | Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value. | 2021 | Details |
| A04981 | 33426876 | J Agric Food Chem | Anti-Inflammatory, Antioxidant, and Anti-Nonalcoholic Steatohepatitis Acylphloroglucinol Meroterpenoids from Hypericum bellum Flowers. | 2021 | Details |
| A04982 | 33426569 | J Med Syst | Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. | 2021 | Details |
| A04983 | 33426540 | J Cell Immunol | Maternal Diet Alters Trained Immunity in the Pathogenesis of Pediatric NAFLD. | 2020 | Details |
| A04984 | 33425805 | Can J Gastroenterol Hepatol | Diospyros kaki and Citrus unshiu Mixture Improves Disorders of Lipid Metabolism in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04985 | 33425804 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. | 2020 | Details |
| A04986 | 33424768 | Front Endocrinol (Lausanne) | Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis. | 2020 | Details |
| A04987 | 33424396 | Saudi J Biol Sci | Regulatory effect of diosgenin on lipogenic genes expression in high-fat diet-induced obesity in mice. | 2020 | Details |
| A04988 | 33424294 | Saudi J Biol Sci | The protective effect of shrimp cooked in different methods on high-cholesterol- induced fatty liver in rats. | 2020 | Details |
| A04989 | 33422644 | Mol Metab | Neonatal overfeeding during lactation rapidly and permanently misaligns the hepatic circadian rhythm and programmes adult NAFLD. | 2021 | Details |
| A04990 | 33422521 | Chem Biol Interact | Phenolic-rich smoothie consumption ameliorates non-alcoholic fatty liver disease in obesity mice by increasing antioxidant response. | 2021 | Details |
| A04991 | 33422007 | BMC Gastroenterol | Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study. | 2021 | Details |
| A04992 | 33421970 | Turk J Med Sci | The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease | 2021 | Details |
| A04993 | 33421947 | EBioMedicine | A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. | 2021 | Details |
| A04994 | 33421884 | Eur J Radiol | The clinical utility of accurate NAFLD ultrasound grading: Results from a community-based, prospective cohort study. | 2021 | Details |
| A04995 | 33421522 | Life Sci | Obesity-induced upregulation of microRNA-183-5p promotes hepatic triglyceride accumulation by targeting the B-cell translocation gene 1. | 2021 | Details |
| A04997 | 33421258 | J Biochem Mol Toxicol | The protective effects of trelagliptin on high-fat diet-induced nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A04999 | 33420074 | Nat Commun | Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. | 2021 | Details |
| A05000 | 33419084 | Antioxidants (Basel) | Antioxidant and Anti-Inflammatory Effects of Korean Black Ginseng Extract through ER Stress Pathway. | 2021 | Details |
| A05001 | 33418491 | Nutrition | Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A05002 | 33417961 | Life Sci | Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity. | 2021 | Details |
| A05003 | 33417955 | Life Sci | Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats. | 2021 | Details |
| A05004 | 33417276 | Mol Syst Biol | Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis. | 2021 | Details |
| A05005 | 33415161 | Biomed Res Int | Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation. | 2020 | Details |
| A05006 | 33414764 | Front Endocrinol (Lausanne) | FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human. | 2020 | Details |
| A05007 | 33413363 | Cardiovasc Diabetol | Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. | 2021 | Details |
| A05008 | 33413060 | Curr Med Chem | Lipid Metabolism and Relevant Disorders to Female Reproductive Health. | 2021 | Details |
| A05009 | 33411984 | J Appl Microbiol | The interplay between host cellular and gut microbial metabolism in NAFLD development and prevention. | 2021 | Details |
| A05010 | 33411970 | J Diabetes Investig | Sex differences in the association between fatty liver and type 2 diabetes incidence in non-obese Japanese: A retrospective cohort study. | 2021 | Details |
| A05011 | 33411880 | Food Funct | Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats. | 2021 | Details |
| A05012 | 33410857 | Food Funct | Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signaling. | 2021 | Details |
| A05013 | 33409973 | Obes Surg | Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis. | 2021 | Details |
| A05014 | 33409801 | Dig Dis Sci | Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05015 | 33409477 | iScience | A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis. | 2020 | Details |
| A05016 | 33409407 | Transl Gastroenterol Hepatol | Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis. | 2021 | Details |
| A05017 | 33409399 | Transl Gastroenterol Hepatol | Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry. | 2021 | Details |
| A05018 | 33409398 | Transl Gastroenterol Hepatol | Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease. | 2021 | Details |
| A05019 | 33409397 | Transl Gastroenterol Hepatol | Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). | 2021 | Details |
| A05020 | 33408593 | EXCLI J | Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction. | 2020 | Details |
| A05021 | 33408301 | Tohoku J Exp Med | Eating Fast and Until Full Is Associated with Elevated Alanine Aminotransferase Activity in Japanese Schoolchildren: A Cross-Sectional Study. | 2021 | Details |
| A05022 | 33408299 | J Toxicol Sci | Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase. | 2021 | Details |
| A05023 | 33407877 | Biol Sex Differ | Analysis of sex differences in dietary copper-fructose interaction-induced alterations of gut microbial activity in relation to hepatic steatosis. | 2021 | Details |
| A05024 | 33407169 | BMC Gastroenterol | Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis. | 2021 | Details |
| A05025 | 33406763 | Int J Mol Sci | Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression. | 2021 | Details |
| A05026 | 33406286 | Int J Clin Pract | Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy. | 2021 | Details |
| A05027 | 33404569 | Food Funct | The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL/6N mice. | 2021 | Details |
| A05028 | 33404223 | J Agric Food Chem | Diosmetin Ameliorates Nonalcoholic Steatohepatitis through Modulating Lipogenesis and Inflammatory Response in a STAT1/CXCL10-Dependent Manner. | 2021 | Details |
| A05029 | 33404166 | Int J Clin Pract | The association of the adipokine zinc-alpha2-glycoprotein with non-alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. | 2021 | Details |
| A05030 | 33401717 | Int J Mol Sci | Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. | 2021 | Details |
| A05031 | 33401222 | Biomed Pharmacother | Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice. | 2021 | Details |
| A05032 | 33401208 | Environ Pollut | Bisphenol F induces nonalcoholic fatty liver disease-like changes: Involvement of lysosome disorder in lipid droplet deposition. | 2020 | Details |
| A05033 | 33400995 | Transl Res | The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology. | 2021 | Details |